Skip to content

Paul Krzyzanowski

Ontario Institute for Cancer Research/Director and Institute Scientist

2021 Salary — last year on the list

$138,859

Total compensation $139,545, including $686 in taxable benefits.

Source: Ontario’s Public Sector Salary Disclosure — names paid $100,000 or more that year. How we build this · Report an error on this page

At a Glance
2021

Employer Rank

#30

Ontario Institute for Cancer Research

Years on List

4

2018–2021

Peak Salary

$138,859

2021

Full 2021 roster at Ontario Institute for Cancer Research →·See where $138,859 ranks →

Total Compensation History

Total compensation by yearLine chart of 4 yearly values of total compensation, from $118,913 in 2018 to $139,545 in 2021.$100K$110K$120K$130K$140K2018201920202021
Total compensation, 2018–2021. Axis starts at $100,000, the Sunshine List disclosure threshold.

Full History
2018–2021

$118,398 in 2018 is worth about $145,734 in 2025 dollars.

Full salary history, by year
YearPositionSalary
2021Director and Institute ScientistOntario Institute For Cancer Research$138,859Benefits $686Total $139,545
2020Director, Genome Technology TranslationOntario Institute For Cancer Research$128,794Benefits $635Total $129,429
2019Director, Genome Technology TranslationOntario Institute For Cancer Research$124,412Benefits $608Total $125,020
2018Director, Genome Technology TranslationOntario Institute for Cancer Research$118,398Benefits $515Total $118,913

On the List
2021

Paul Krzyzanowski's $138,859 salary at Ontario Institute for Cancer Research was about 13% above the 2021 median there, $123,270. Paul Krzyzanowski was the #30 highest-paid of 83 people Ontario Institute for Cancer Research disclosed in 2021, with total compensation of $139,545. The 2021 Sunshine List recorded 244,456 disclosures of $100,000 or more. Records under this name have appeared on the Sunshine List at Ontario Institute for Cancer Research 4 years in all, 2018–2021.

Also at Ontario Institute for Cancer Research
2021

View all 83 employees at Ontario Institute for Cancer Research (2021) →